Back to search
FDAFDA · Food and drugs·Recall number D-1317-2014

Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box, Manufactured by: Sujie Pharmaceutical Ltd., Tokyo, Japan, UPC 4973430081576

Published May 21, 2014 · Recall initiated: April 29, 2014

Summary

FDA records drug Class II recall D-1317-2014, published May 21, 2014 and initiated April 29, 2014. Recalling firm: Flawless Beauty LLC; Status: Completed; Reported quantity: unknown; Lot: Lot #: UB302, Exp 05/12/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Flawless Beauty LLC
Distributor
Nationwide
UPC
4973430081576
Lot
Lot #: UB302, Exp 05/12/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials, 1200 mg/200 mg, 10-count vials per box, Manufactured by: Sujie Pharmaceutical Ltd., Tokyo, Japan, UPC 4973430081576 recalled?

Yes. FDA published recall D-1317-2014 on May 21, 2014. Reported hazard: Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 4973430081576.